Fungal lung infections in ICU patients with weak immune systems
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study looks at different types of fungi that may cause serious lung infections in patients with weakened immune systems in the ICU. It aims to find out which fungi are present and which antifungal drugs can kill them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and in the ICU with pneumonia.
- You have not gotten better after 48 hours of antibiotics, or a CT scan suggests a fungal infection.
- You have one or more of these conditions: pre-existing lung disease (like COPD), a weakened immune system (from medicines, low white blood cells, or an immune disorder), diabetes, kidney or liver disease, or cancer (blood or solid tumor).
- You are willing to have a sample taken (like phlegm, fluid, or tissue) for testing.
- You are not refusing to be part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
This study looks closely at how influenza (the flu) and a specific kind of lung fungus called Aspergillus affect people who are sick in the ICU with breathing problems. It may help doctors better understand the cause and improve treatment for severe lung infections.
This study is developing a tool to better predict fungal pneumonia in people who come to the emergency department or hospital with pneumonia. By analyzing samples from your lungs and other data, researchers hope to improve diagnosis and treatment decisions.
This study looks for fungal infections in hospitalized patients. It aims to understand how common serious fungal infections are, especially in people with weakened immune systems or certain medical conditions.
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
Hear when a new Immunocompromised ICU Patients With Respiratory Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.